Skip to main content

1-1 of 1 results for subject:Reviews

Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

To ask the Secretary of State for Health and Social Care, whether he has had discussions with relevant stakeholders on reviewing prescription guidelines following the decision by the Competition and Markets Authority to fine Advanz for the inflation of the price of Liothyronine.

Asked by
Justin Madders (Labour)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
13 April 2022
Reference
144938
House
House of Commons